key: cord-1044882-25k9tvyk authors: Bermúdez‐Forero, María‐Isabel; Soto‐Viáfara, Jonathan‐Andrés; Gardeazábal‐Acuña, Paula‐Andrea; Anzola‐Samudio, Diego‐Alexander; García‐Otálora, Michel‐Andrés title: Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system date: 2021-10-24 journal: Transfus Med DOI: 10.1111/tme.12828 sha: e25d06e72dfe1eb3f01307e9f5797b562ad107d1 doc_id: 1044882 cord_uid: 25k9tvyk OBJECTIVE: This work aimed to establish the effects of the COVID‐19 pandemic on blood collection and blood product usage at the end of the first year. BACKGROUND: The arrival of SARS‐CoV‐2 to Colombia on March 6, 2020, triggered closure of borders and mandatory lockdown from March 23, 2020. METHODS/MATERIALS: The Colombian National Institute of Health administers the National database of confirmed cases of SARS‐CoV‐2 and the National Haemovigilance System. We examined positive SARS‐CoV‐2 cases identified between March 6, 2020, and March 6, 2021, using positive RT‐PCR testing (72.8%) or reactive antigen (27.2%). We also analysed accepted and deferred donors' information provided by 100% of blood banks and transfused patients notified by 83% of health care facilities nationwide, between March 1, 2019, to February 28, 2021. RESULTS: Colombia registered 2 273 245 SARS‐CoV‐2 cases. From these, 60 412 people died from COVID‐19 (2.7%) and 2 172 418 individuals recovered (95.6%). There were 11 659 216 SARS‐CoV‐2 processed samples nationwide. People between the ages of 20 and 39 years concentrated 44.4% of the SARS‐CoV‐2 cases. There were 773 569 blood donations, mainly from a 20‐39‐year‐old population (60.5%). The pandemic caused a reduction of 155 393 blood donations (16.7%) and 51 823 total deferrals (33.7%). An 18.4% drop in volunteer donors and a 37.3% increase in donations from family/replacements members were observed. There were 399 453 transfused patients and 1 179 895 blood components administered (−8.7% and − 13.9% compared to March 2019–February 2020). CONCLUSION: Mandatory lockdowns in Colombia decreased blood collection and usage, resulting in a reduction of blood components transfused to individual patients. In December 2019, investigators identified the emergence of a new coronavirus (SARS-CoV-2) in Wuhan, China, 1 which rapidly spread worldwide. 2 The virus is responsible for causing the coronavirus 19 disease (COVID- 19) , which was declared a pandemic by the World Health Organisation (WHO) on March 11th, 2020. 2 On March 6, 2020, the first case of a person positive for SARS-Cov-2 in Colombia was made official. 3 On March 21, 2020, the first national death from COVID-19 occurred 4 and as of March 23, the Colombian government declared the national health emergency, the closure of borders, and mandatory confinement until August 1, 2020, 5 which helped reduce the basic reproduction number (R 0 ) from 4.8 to 2.2. 6 Subsequent research identified the arrival of SARS-CoV-2 to the country predominantly from Europe and North America, with the B1 and B1.5 lineages being the most widespread. 6 One of the main concerns as mandatory confinements were established in the countries to fight the pandemic was the drop in blood collections and availability. [7] [8] [9] [10] For example, India and China reported a drop in blood donors by more than 67% after the massive suspension of blood donation campaigns. 11, 12 However, several compensatory measures, such as deferrals of elective and non-urgent surgeries, were implemented in hospitals to deal with shortage. 13, 14 These measures have reduced the demand for blood components by up to 84%. 11, 15 Additionally, government entities such as the Food and Drug Administration (FDA) in the United States of America, 16 18 that collects and publish 19 information from 1386 qualified laboratories. Likewise, INS coordinates the country's blood network, formed by 30 public and 53 private blood banks 20 that collect 93% whole blood and 7% apheresis annually 21 and more than 580 health care facilities that transfuse blood. 22 The blood donation rate in Colombia changed from 18.5/1000 inhabitants in 1995 23 to 25.1 in 2020. 21 Likewise, blood donation from family/replacement went from 44.2% in 2005 24 to 7.3% in 2020, 21 The variables included were blood components transfused to patients according to the hospital service, age-range, and sex. We reported values of analysed variables using the mean and SD or the median and interquartile range 25- To establish the potential donors' outcomes, we analysed acceptance and deferral rates (including suspicion of SARS-CoV-2 infection), Table 1 To establish whether all hospital services reduced the number of patients and blood components used, we compared the results reported by each medical specialty before and during pandemic (Table 3) . We identified that oncology, neonatology and burn unit, increased 7.9% the number of patients seen during pandemic (Figure 3 ). In contrast, the remaining 21 specialties presented an interannual variation of À16.7%. Finally, we established whether there were changes in the number of transfused patients based on sex and age before and during the pandemic. In the 2020-2021 period, the population aged 0-1 years increased. 29 Similarly, Chandler et al., identified that the mean age of blood donors in seven European countries during the COVID-19 crisis was 42 years. 9 These results suggest that Colombian blood donors were younger than their peers in North America and Europe. We identified a 36.1% decrease in the assistance of potential donors to blood banks nationwide after the state of emergency declaration, which partially recovered by 24.7% after reopening sectors, restrictions. 30 The WHO suggested in July 2020 a temporary deferral to potential blood donors exposed to SARS-CoV-2 for 14 days. 14 procedures in US, the most common reasons were the availability of ICU beds, blood availability, and the COVID-19 case burden. 48 The number of institutions that reported an increase in blood waste inventories doubled due to changes related to COVID-19. 49 At the Ramon y Cajal hospital in Madrid the demand for blood in surgery fell 50.2% during the pandemic, while the ICU grew by 116%. Haematology and oncology did not show variations. 46 We identified a statistically significant drop in both supply and demand for all blood components during the pandemic, especially RBC units since the second half of 2020. We also found the greatest variation in blood components transfused per patient at transplantation and cardiothoracic surgery services. It was impossible to know these patients' clinical outcomes; then, we could not define whether the reduction in blood components per patient (especially RBC units) impacted their morbidity and mortality. However, multiple systematic reviews have shown in various settings that restrictive versus liberal blood use does not negatively affect 30-day survival. [50] [51] [52] Additional studies are warranted to determine this effect. In conclusion, this work showed that SARS-CoV-2 infection was detected in all age ranges of the population. However, people between the ages of 20 to 39 years concentrated 44.4% of the cases. Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus disease (COVID-19) pandemic. Regional office for Europe Colombia confirma su primer caso de COVID-19 Colombia confirma primera muerte por coronavirus. Ministerio de Salud y Protecci on Social Decreto 637 (Gobierno de la República de Colombia) The arrival and spread of SARS-CoV-2 in Colombia Critical blood shortages because of COVID-19. Mayo Clinic AABB, America's Blood Centers Blood donation in times of crisis: early insight into the impact of COVID-19 on blood donors and their motivation to donate across European countries The impact of COVID-19 pandemic on blood supplies and transfusion services in eastern Mediterranean region The blood supply management amid the COVID-19 outbreak Impact of COVID-19 on blood centres in Zhejiang province China Effects of the COVID-19 pandemic on supply and use of blood for transfusion World Health Organization, Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington state Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency. Guidance for Industry (Food and Drug Administration Red Bancos de Sangre y Servicios de Transfusi on-Pandemia COVID-19 Sismuestras / Pruebas serol ogicas Instituto Nacional de Salud Informe de diagn ostico de la red nacional bancos de sangre Colombia Informe ejecutivo de la Red Nacional Servicios de Transfusi on Tamizaje de enfermedades infecciosas en bancos de sangre, Colombia Informe anual red sangre development and implementation of a haemovigilance system in Colombia (SIHEVI) Instituto Nacional de Salud Nacional de poblaci on y vivienda Demographic Trends of COVID-19 cases and deaths in the US reported to CDC Blood banks face a generation gap in giving Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran SARS-CoV-2 RNAemia in a healthy blood donor 40 days after respiratory illness resolution Assessment of blood supply and usage pre-and during COVID-19 pandemic: a lesson from non-voluntary donation Blood donor selection: Guidelines on Assessing Donor Suitability for Blood Donation (WHO) Global Status Report on blood Safety and availability 2016. (WHO) Caso 1-2019: Notificaci on de una Infecci on Trasmitida por Transfusi on (ITT)-Virus de Inmunodeficiencia Humana (VIH) identificada por genotipificaci on The prevalence of antibodies to SARS-CoV-2 among blood donors in China Post-donation COVID-19 identification in blood donors Seroprevalence of SARS-CoV-2 among blood donors and changes after Introduction of public health and social measures A systematic review and meta-analysis of antecedents of blood donation behavior and intentions A novel approach to detect test-seeking behaviour in the blood donor population: making the invisible visible Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation Post-donation information and haemovigilance reporting for COVID-19 in Greece: information supporting the absence of SARS-CoV-2 possible transmission through blood components Transfusion support in COVID-19 patients: impact on hospital blood component supply during the outbreak Transfusion services operations during the COVID-19 pandemic: Results from AABB survey COVID-19 Weekly Hospital Transfusion Service Survey Blood banking and transfusion medicine challenges during the COVID-19 pandemic Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials Effect of a restrictive vs Liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial Effect of the first year of COVID-19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system Accepted blood donations according to type of donor. Comparison before and during the pandemic Month Voluntary unpaid Family/replacement The authors have no competing interests. Michel-Andrés García-Otálora https://orcid.org/0000-0001-9637-